Year |
Citation |
Score |
2016 |
Wu W, Panté N. Vimentin plays a role in the release of the influenza A viral genome from endosomes. Virology. 497: 41-52. PMID 27423069 DOI: 10.1016/j.virol.2016.06.021 |
0.334 |
|
2016 |
Ding X, Lu J, Yu R, Wang X, Wang T, Dong F, Peng B, Wu W, Liu H, Geng Y, Zhang R, Ma H, Cheng J, Yu M, Fang S. Preliminary Proteomic Analysis of A549 Cells Infected with Avian Influenza Virus H7N9 and Influenza A Virus H1N1. Plos One. 11: e0156017. PMID 27223893 DOI: 10.1371/journal.pone.0156017 |
0.38 |
|
2016 |
Zhou LC, Liu J, Pei EL, Xue WJ, Lyu JM, Cai YT, Wu D, Wu W, Liu YY, Jin HY, Gao YW, Wang ZH, Wang TH. Novel Avian Influenza A(H5N8) Viruses in Migratory Birds, China, 2013-2014. Emerging Infectious Diseases. 22: 1121-1123. PMID 27192098 DOI: 10.3201/eid2206.151754 |
0.37 |
|
2016 |
Fang S, Wang X, Dong F, Jin T, Liu G, Lu X, Peng B, Wu W, Liu H, Kong D, Tang X, Qin Y, Mei S, Xie X, He J, et al. Genomic characterization of influenza A (H7N9) viruses isolated in Shenzhen, Southern China, during the second epidemic wave. Archives of Virology. PMID 27169600 DOI: 10.1007/s00705-016-2872-1 |
0.371 |
|
2016 |
Wolf S, Wu W, Jones C, Perwitasari O, Mahalingam S, Tripp RA. MicroRNA Regulation of Human Genes Essential for Influenza A (H7N9) Replication. Plos One. 11: e0155104. PMID 27166678 DOI: 10.1371/journal.pone.0155104 |
0.357 |
|
2005 |
Macdonald SJ, Cameron R, Demaine DA, Fenton RJ, Foster G, Gower D, Hamblin JN, Hamilton S, Hart GJ, Hill AP, Inglis GG, Jin B, Jones HT, McConnell DB, McKimm-Breschkin J, ... ... Wu WY, et al. Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza. Journal of Medicinal Chemistry. 48: 2964-71. PMID 15828835 DOI: 10.1021/jm040891b |
0.696 |
|
2004 |
Macdonald SJ, Watson KG, Cameron R, Chalmers DK, Demaine DA, Fenton RJ, Gower D, Hamblin JN, Hamilton S, Hart GJ, Inglis GG, Jin B, Jones HT, McConnell DB, Mason AM, ... ... Wu WY, et al. Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen. Antimicrobial Agents and Chemotherapy. 48: 4542-9. PMID 15561823 DOI: 10.1128/AAC.48.12.4542-4549.2004 |
0.7 |
|
2004 |
Watson KG, Cameron R, Fenton RJ, Gower D, Hamilton S, Jin B, Krippner GY, Luttick A, McConnell D, MacDonald SJ, Mason AM, Nguyen V, Tucker SP, Wu WY. Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase. Bioorganic & Medicinal Chemistry Letters. 14: 1589-92. PMID 15006410 DOI: 10.1016/j.bmcl.2003.09.102 |
0.695 |
|
2003 |
Watson KG, Brown RN, Cameron R, Chalmers DK, Hamilton S, Jin B, Krippner GY, Luttick A, McConnell DB, Reece PA, Ryan J, Stanislawski PC, Tucker SP, Wu WY, Barnard DL, et al. An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirus. Journal of Medicinal Chemistry. 46: 3181-4. PMID 12852746 DOI: 10.1021/Jm0202876 |
0.656 |
|
Show low-probability matches. |